[
    [
        {
            "time": "2018-01-03",
            "original_text": "Dr. Reddy's (RDY) to Report Q3 Earnings: What's in Store?",
            "features": {
                "keywords": [
                    "Dr. Reddy's",
                    "Q3 Earnings",
                    "Report"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Dr. Reddy's (RDY) to Report Q3 Earnings: What's in Store?",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-01-04",
            "original_text": "Allergan Hikes Quarterly Dividend by 2.8% Ahead of Q4 Results",
            "features": {
                "keywords": [
                    "Allergan",
                    "Quarterly Dividend",
                    "Hikes",
                    "2.8%",
                    "Q4 Results"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Allergan Hikes Quarterly Dividend by 2.8% Ahead of Q4 Results",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-05",
            "original_text": "The Zacks Analyst Blog Highlights: J&J, Bristol-Myers, Lilly, AbbVie and Merck",
            "features": {
                "keywords": [
                    "Zacks Analyst Blog",
                    "J&J",
                    "Bristol-Myers",
                    "Lilly",
                    "AbbVie",
                    "Merck"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "The Zacks Analyst Blog Highlights: J&J, Bristol-Myers, Lilly, AbbVie and Merck",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]